Disorders of Metabolism



Disorders of Metabolism


Kurt Hirschhorn M.D.

Judith Willner M.D.


Clinical Pearls

(KH)

(JW)




Alkaptonuria


Synonym

Ochronosis


Inheritance

Autosomal recessive; homogentisate 1,2-dioxygenase (HGO) gene on 3q21-q23


Prenatal Diagnosis

DNA analysis


Incidence

1:250,000; increased in Dominican Republic, Slovakia; M=F


Age at Presentation

Childhood (dark cerumen, black-stained underwear) to adulthood (skin pigment, arthropathy)


Pathogenesis

Mutations in the HGO gene leads to deficiency of homogentisic acid oxidase with secondary accumulation of homogentisic acid in connective tissue


Key Features


Skin

Blue-gray pigmentation increased on nose, cheeks, forehead, axillae; blue-gray pigmented cartilage and tendons visualized through skin on ears, nose tip, extensor hands, costochondral junctions; brown/black cerumen, sweat


Eyes

Blue-gray scleral pigment


Musculoskeletal

Severe arthropathy involving larger joints including hip, knee, shoulder, spine; intervertebral disc calcification


Genitourinary

Dark urine with pH above 7.0 (diapers, clothing discolored after cleansing with alkaline soaps)


Cardiovascular

Mitral and aortic valvulitis; increased incidence of myocardial infarction later in life


Differential Diagnosis

Exogenous ochronosis (antimalarials, hydroquinone)

Argyria

Chrysoderma

Amiodarone administration


Laboratory Data

Enzyme assay: measurement of urinary homogentisic acid

Darkening of urine with addition of NaOH

Spine films

Electrocardiogram (ECG) in older patients


Management

Analgesics, physical therapy, joint replacement for arthropathy

Supplemental vitamin C up to 1 g per day for older children and adults

Reduction of phenylalanine and tyrosine may help reduce homogentisate excretion


Prognosis

Normal life span with persistent pigmentation changes and unremitting arthropathy; older patients with increased incidence of myocardial infarction







image







11.1. Blue-gray pigmentation involving ear cartilage. (120)






11.2. Similar pigmentation on patient’s hands. (120)



Fabry Disease


Synonym

Angiokeratoma corporis diffusum


Inheritance

X-linked recessive; α-galactosidase A (GLA) gene on Xq21.33-q22


Prenatal Diagnosis

Chorionic villus sampling (CVS)/amniocentesis—α-galactosidase A enzyme assay DNA analysis


Incidence

Approximately 1:40,000 males; female heterozygotes reported with marked variability in expression


Age at Presentation

Childhood to adolescence


Pathogenesis

Mutation in GLA leads to defective activity of α-galactosidase A and accumulation of neutral glycosphingolipids with preferential deposition in vascular endothelium resulting in ischemia and infarction; also deposits within most tissues of the body, including heart and kidney


Key Features


Skin

Angiokeratomas—dark red to blue-black papules with/without overlying hyperkeratosis concentrated symmetrically between the umbilicus and knees, increase in number and size with age; hypoanhidrosis


Mucous Membranes

Angiokeratomas—oral mucosa, conjunctiva


Peripheral Nervous System

Painful crises—most severe on hands and feet but can spread proximally; exercise, fever, climate/temperature changes, emotional stress may trigger episode Acroparesthesias—constant discomfort of hands and feet with burning, tingling paresthesias


Cardiovascular

Angina, myocardial infarction, conduction defects, mitral insufficiency


Kidney

Progressive renal deterioration with proteinuria, birefringent lipid globules (“maltese crosses”) seen with polarizing microscopy, renal failure


Central Nervous System

Peripheral neuropathy, cerebrovascular accidents


Eyes

Characteristic corneal opacities with whorl-like configuration, lenticular opacities, dilated and tortuous conjunctival and retinal vessels


Differential Diagnosis

Rheumatic fever

Mercury/heavy metal poisoning

Erythromelalgia

Other angiokeratomas: angiokeratoma of Fordyce, fucosidosis, sialidosis, β-galactosidase deficiency, aspartylglucosaminuria



Laboratory Data

DNA analysis

Enzyme assay—deficient α-galactosidase A activity

Skin, bone marrow biopsy

Urinary sediment examination with polarizing microscopy

Slit-lamp ophthalmologic examination

ECG


Management

α-Galactosidase A intravenous replacement therapy

Diphenylhydantoin, carbamazepine—pain crises

Symptomatic care of cardiac, central nervous system (CNS), and ocular manifestations

Long-term hemodialysis, renal transplantation

Advise physical education teachers/occupational advice—minimize physical/emotional stresses


Prognosis

Premature death during fifth decade secondary to myocardial infarction, cerebrovascular accidents, and renal failure; enzyme replacement therapy, hemodialysis, renal transplantation may extend life span








11.3. Angiokeratomas on penile shaft, scrotum, groin, and inner thigh. (121)






11.4. Angiokeratomas studding the labial mucosa. (122)






image




Gaucher Disease


Inheritance

Autosomal recessive; acid-β-glucocidase (GBA) gene locus 1q21


Prenatal Diagnosis

CVS/amniocentesis—glucocerebrosidase enzyme assay

Ultrasound: hydrops fetalis, hepatosplenomegaly may be seen in type II disease

DNA analysis


Incidence

Over 350 patients reported; type I is 20 times more common than type II and increased in Ashkenazi Jewish population; M=F


Age at Presentation

Type II (infantile)—2 to 3 months of life

Type I (adult)—may begin within first decade of life; usually begins later in adulthood


Pathogenesis

Mutation in GBA gene leads to decreased glucocerebrosidase activity resulting in accumulation of glucocerebroside in histiocytes (Gaucher’s cells) in spleen, liver, bone marrow, lymph nodes, and brain (infantile only); adult form without CNS accumulation secondary to adequate neuronal glucocerebrosidase activity


Key Features


Type I (Adult)


Skin

May have diffuse hyperpigmentation on face, neck, hands; petechiae, ecchymoses


Musculoskeletal

Bone pain, fractures with thinned cortex, vertebral collapse, aseptic necrosis of femoral head


Gastrointestinal

Hepatomegaly, hypersplenism with secondary pancytopenia, hemorrhage


Lymphatics

Enlarged lymph nodes


Eyes

Pingueculae


Type II (Infantile) Central Nervous System

Hypertonicity, neck rigidity, laryngeal spasm, difficulty swallowing, catatonia, developmental retardation


Gastrointestinal

Hepatosplenomegaly


Lungs

Chronic aspiration, fatal bronchopneumonia


Type III

Rarest, rapidly deteriorates like type II; hepatosplenomegaly, bone involvement, strabismus, slow neurodegeneration


Differential Diagnosis

Niemann-Pick disease (p. 314)

Other lysosomal storage diseases



Laboratory Data

Serum glucocerebrosidase enzyme assay

Bone marrow biopsy—Gaucher cells

Bone x-rays

Serum acid phosphatase elevated


Management

Type II—supportive care, antibiotics

Type I—enzyme replacement, bone marrow transplant, splenectomy, referral to orthopedic surgeons for conservative management, referral to hematologist-oncologist


Prognosis

Type II—fatal by 1 to 2 years of age secondary to aspiration pneumonia

Type I—variable life span, potential premature death secondary to infection, anemia, hemorrhage without treatment; many may achieve a normal life span








11.5. X-ray depicting tapered femoral midshaft with widening of the distal femur-characteristic “Ehrlenmeyer flask” deformity. (123)






11.6. Gaucher cell—lipid-engorged macrophage with characteristic “crumpled tissue paper” appearance obtained from bone marrow. (48)






image




Niemann-Pick Disease


Inheritance

Autosomal recessive; sphingomyelin phosphodiesterase-1 (SMPD-1) gene locus 11p15.4-15.1 (types A, B)

Type C—gene locus 18p


Prenatal Diagnosis

CVS/amniocentesis—sphingomyelinase enzyme assay from cultured chorionic villus tissue/amniotic fluid cells

DNA analysis


Incidence

Type A most common—over 50% are Ashkenazi Jews; a few hundred cases reported; M=F


Age at Presentation

Type A—infancy

Type B—infancy to childhood

Type C—childhood


Pathogenesis

Mutations in SMPD-1 results in acid sphingomyelinase deficiency in types A and B with subsequent accumulation of sphingomyelin in characteristic foam cells within all organs, increased in brain (except type B), liver, spleen, lymph nodes, and lungs; cholesterol esterification defect in type C with normal sphingomyelinase


Key Features


Type A


Skin

Xanthomas; yellow-brown, waxy induration on exposed surfaces


Central Nervous System

Progressive psychomotor deterioration, hypotonicity, muscle weakness


Gastrointestinal

Hepatosplenomegaly, emaciated appearance—failure to thrive, vomiting


Lymphatics

Generalized enlarged lymph nodes


Eyes

Blindness, cherry red spots


Ear-Nose-Throat

Deafness


Lungs

Bronchopneumonia, infiltration of foam cells


Type B

CNS spared, otherwise similar to type A


Type C

Developmental delay, hepatosplenomegaly, progressive psychomotor deterioration



Differential Diagnosis

Gaucher disease (p. 310)

Tay-Sachs disease


Laboratory Data

Serum sphingomyelinase assay

Bone marrow biopsy


Management

Supportive care—parenteral nutrition, antibiotics, transfusions, splenectomy

Bone marrow transplant—type B


Prognosis

Type A—death by 2 to 3 years of age secondary to progressive deterioration, fatal pulmonary infection

Type B—death in adolescence; may survive into adulthood

Type C—death in adolescence








11.7. Cherry red spot in fovea. (124)






11.8. Niemann-Pick cell—foamy histiocyte obtained on bone marrow biopsy. (48)






image




Mucopolysaccharidoses


Inheritance

Autosomal recessive except X-linked recessive in Hunter’s syndrome


Gene loci

Hurler, Scheie syndrome—4p16.3

Hunter’s syndrome—Xq27.3-q28

Sanfilippo syndrome—several loci reported

Morquio syndrome (A)—16q24.3

Maroteaux-Lamy syndrome—5q11-q13


Prenatal Diagnosis

CVS/amniocentesis—enzyme assay from cultured chorionic villus tissue/amniotic fluid cells

DNA analysis


Incidence

Hurler’s—approximately 1:100,000; M=F

Scheie’s—rare; M=F

Hunter’s—approximately 1:100,000; all males

Sanfilippo’s—approximately 1:25,000; M=F

Morquio’s—<1:100,000; M=F

Maroteaux-Lamy’s—rare; M=F


Age at Presentation

Hurler’s, Hunter’s, Sanfilippo’s, Morquio’s, Maroteaux-Lamy—normal at birth, within first 2 years of life Scheie’s—birth (corneal clouding, herniae); childhood (stiff joints)


Pathogenesis

Lysosomal enzymes responsible for breakdown of mucopolysaccharides are deficient; increased mucopolysaccharides throughout system


Syndrome: Enzyme; Mucopolysaccharides

Hurler’s, Scheie: α-L-iduronidase; dermatan, heparan sulfate

Hunter’s: iduronate sulfatase; dermatan, heparan sulfate

Sanfilippo’s: (A) heparan-N-sulfatase, (B) α-N acetylglucosaminidase, (C) acetyl-CoA: α-glucosaminide acetyltransferase, (D) N-acetylglucosamine 6-sulfatase; heparan sulfate

Morquio’s: (A) hexosamine 6-sulfatase, (B) beta-galactosidase; keratan sulfate

Maroteaux-Lamy’s: arylsulfatase B; dermatan sulfate


Key Features


Skin

Firm, ivory-colored papules symmetrically distributed between angles of the scapulae and posterior axillary line (Hunter)

Thick, coarse (all)


Hair

Generalized hirsutism (all)


Craniofacial

Coarse facies with thick nose and depressed nasal bridge, thick lips and tongue, short neck, macrocephaly (Hurler’s, Hunter’s, Sanfilippo’s—mild, Maroteaux-Lamy’s)


Central Nervous System

Mental retardation (Hurler’s, Hunter’s—severe form, Sanfilippo’s), progressive neurologic impairment (Hunter’s—severe form, Sanfilippo’s), deafness (Hurler’s, Hunter’s), hyperactivity/behavioral problems (Sanfilippo’s), hydrocephalus (Hurler’s, Hunter’s—severe form)


Musculoskeletal

Short stature (all except Scheie’s), broad hands with short fingers (all), “dysostosis multiplex”—stiff joints, contractures, kyphoscoliosis, claw deformity of hand (Hurler’s, Scheie’s, Hunter’s, Maroteaux-Lamy’s), odontoid hypoplasia (Morquio’s, Hurler’s), joint laxity (Morquio’s), lumbar lordosis (Morquio’s), umbilical/inguinal hernia (Hurler’s, Scheie’s, Hunter’s, Maroteaux-Lamy’s)



Eyes

Corneal clouding (all except Hunter’s, Sanfilippo’s)


Cardiovascular

Deposition of mucopolysaccharides with valvular and coronary heart disease (Hurler’s, Scheie’s, Hunter’s, Morquio’s, Maroteaux-Lamy’s), aortic valve disease (Scheie’s)


Gastrointestinal

Hepatosplenomegaly (Hurler’s, Hunter’s, Maroteaux-Lamy’s)


Lungs

Bronchopneumonia—often end-stage, sleep apnea with narrow upper airway (Hurler’s, Scheie’s, Hunter’s, Maroteaux-Lamy’s)


Differential Diagnosis

Mucolipidoses


Laboratory Data

Mucopolysaccharide detection in urine

Enzyme assay: fibroblasts, leukocytes, serum

Spine films

Echocardiogram


Management

Supportive care with physical therapy, special education, hearing aids

Surgical correction of cornea, cardiac valve, cervical spine, joint contractures, hernia may help

Bone marrow transplantation—some success


Prognosis

Progressive worsening with no cure; death usually within second decade because of respiratory/cardiac decompensation; milder forms may survive into adulthood Scheie’s—normal life span








11.9. Typical coarse facies in a girl with Hurler syndrome.






11.10. Broad hands with short fingers, thick coarse skin. (1)






11.11. Ivory-colored papules in “cobblestone” pattern between scapula and posterior axillary line in patient with Hunter’s syndrome. (125)






image




Multiple Carboxylase Deficiency


Synonym

Biotinidase deficiency

Holocarboxylase synthetase deficiency


Inheritance

Both autosomal recessive; holocarboxylase synthetase (HLCS) gene on 21q22; biotinidase (BTD) gene on 3p25


Prenatal Diagnosis

CVS/amniocentesis: biotinidase or holocarboxylase synthetase assay


Incidence

Biotinidase deficiency: 1:70,000 to 80,000; M=F

Holocarboxylase synthetase deficiency: unknown, rare: M=F


Age at Presentation

Biotinidase deficiency: approximately 6 months old

Holocarboxylase synthetase deficiency: first few days to months of life


Pathogenesis

Mutations in HLCS or BTD render the patient deficient in holocarboxylase synthetase or biotinidase respectively, resulting in decreased free serum biotin and metabolic acidosis with resultant phenotype


Key Features


Skin

Periorificial/generalized dermatitis with/without candida infection


Hair

Sparse to total alopecia


Central Nervous System

Hypotonia, seizures, ataxia, coma


Gastrointestinal

Vomiting (holocarboxylase synthetase deficiency)


Eyes

Optic atrophy (biotinidase deficiency)


Ear-Nose-Throat

High-frequency hearing loss (biotinidase deficiency)


Metabolism

Metabolic acidosis, hyperammonemia, organic aciduria


Differential Diagnosis

Atopic dermatitis

Seborrheic dermatitis

Acrodermatitis enteropathica (p. 328)

Mucocutaneous candidiasis

Essential fatty acid deficiency


Laboratory Data

Screen urine for organic aciduria

Serum biotinidase/holocarboxylase synthetase assay

Screen blood—metabolic acidosis, hyperammonemia


Management

Biotin 10 mg per day for life


Prognosis

If biotin instituted prior to neurologic sequelae, normal life span with normal growth and development







image







11.12. Infant with alopecia, hypotonia, and groin dermatitis. (5)






11.13. Sparse, lusterless, brittle scalp hair on close-up view. (5)



Phenylketonuria


Inheritance

Autosomal recessive; phenylalanine hydroxylase (PAH) gene locus 12q24.1


Prenatal Diagnosis

CVS/amniocentesis—enzyme assay, metabolite levels, DNA analysis


Incidence

1:10,000 caucasian births; M=F


Age at Presentation

Birth


Pathogenesis

Mutation in PAH leads to a deficiency of phenylalanine hydroxylase with subsequent accumulation of phenylalanine and its metabolites; increased phenylalanine competitively inhibits tyrosine in melanogenesis and has toxic affects on the CNS


Key Features


Skin

Generalized hypopigmentation, eczematous dermatitis, sclerodermoid changes


Hair

Blonde


Eyes

Blue


Central Nervous System

Mental retardation, seizures, hyperreflexia, psychomotor delay


Differential Diagnosis

Albinism

Chédiak-Higashi syndrome (p. 62)

Scleroderma/morphea


Laboratory Data

Urine (mousy odor), blood screen for phenylalanine and its metabolites


Management

Routine neonatal screening

Low-phenylalanine diet instituted early on will prevent CNS and skin changes


Prognosis

Normal life span with normal intelligence with treatment; without treatment shortened life span with chronic seizures and mental retardation







image







11.14. Lighter hair color in affected Japanese child compared to unaffected mother. (126)






11.15. Sclerodermoid changes on buttocks and thigh of 1-year-old. (127)



Wilson’s Disease


Synonym

Hepatolenticular degeneration


Inheritance

Autosomal recessive; ATB7B gene on 13q14.2-q21


Prenatal Diagnosis

DNA analysis


Incidence

1:50 to 100,000: M=F


Age at Presentation

Childhood to adulthood


Pathogenesis

Mutation in ATB7B, a gene encoding an adenosine triphosphatase (ATPase) CU2+-transporting polypeptide results in a defect in biliary excretion of copper/copper transport and leads to accumulation of copper in liver, brain, cornea

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 25, 2016 | Posted by in Dermatology | Comments Off on Disorders of Metabolism

Full access? Get Clinical Tree

Get Clinical Tree app for offline access